ABSTRACT NUMBER: ESOC2026A915 REAL-WORLD NEUROLOGICAL AND FUNCTIONAL RECOVERY AFTER STROKE: BASELINE-CONTROLLED OUTCOMES ASSOCIATED WITH MLC901 USE
Anita Arsovska · 2026
Read ABSTRACT NUMBER: ESOC2026A915 REAL-WORLD NEUROLOGICAL AND FUNCTIONAL RECOVERY AFTER STROKE: BASELINE-CONTROLLED OUTCOMES ASSOCIATED WITH MLC901 USE by Anita Arsovska (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13146912.txt.
Description
Anita Arsovska reports real-world stroke recovery data in 2026 for patients treated with a drug used as an add-on in recovery. Stroke often leaves lasting weakness and loss of independence, and few proven options aid recovery after the first days. The drug, named MLC901 in the report, is used to support later recovery, but everyday outcome data are scarce.
The report draws on a safety registry covering 108 patients in North Macedonia treated between 2018 and 2025. At three months, scores for nerve damage and daily function had both improved clearly from the start point. Follow-up was nearly complete, and the drug was well tolerated with no serious linked side effects reported.
Catalog record
| CREATOR | Anita Arsovska |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 2 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |